Similar articles

• Atrial fibrillation and stroke risk prevention in real-life clinical practice.

  Tay KH, Lip GY, Lane DA. Tay KH, et al. Thromb Haemost. 2009 Mar;101(3):415-6. Thromb Haemost. 2009. PMID: 19277398 No abstract available.
• [Thromboembolism in non-rheumatic atrial fibrillation].

  Pengo V. Pengo V. Haematologica. 2001 Sep;86(9 Suppl):5-11. Haematologica. 2001. PMID: 11759619 Review. Italian. No abstract available.
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

  Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators. Flaker GC, et al. Am Heart J. 2006 Nov;152(5):967-73. doi: 10.1016/j.ahj.2006.06.024. Am Heart J. 2006. PMID: 17070169
• Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.

  Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Jacobs LG, et al. Am J Geriatr Pharmacother. 2009 Jun;7(3):159-66. doi: 10.1016/j.amjopharm.2009.06.002. Am J Geriatr Pharmacother. 2009. PMID: 19616184
• [Acetylsalicylic acid versus coumarin derivatives in atrial fibrillation].

  Verheugt FW. Verheugt FW. Ned Tijdschr Geneeskd. 2000 Dec 2;144(49):2336-40. Ned Tijdschr Geneeskd. 2000. PMID: 11129967 Review. Dutch.